Synopsis of recent research by authors named "Sheng-Yong Yu"
- Sheng-yong Yu's research primarily focuses on catecholaminergic polymorphic ventricular tachycardia (CPVT), examining long-term outcomes and predictive factors associated with ventricular arrhythmia in affected patients.
- The studies involve detailed clinical assessments of patients, including electrocardiograms, Holter monitoring, and genetic testing (notably for mutations in RYR2 and CASQ2), to better understand the clinical features and therapeutic effectiveness.
- Findings indicate that β-blockers are the recommended treatment for CPVT, with additional therapies like propafenone and renal sympathetic denervation being explored for certain patients to improve long-term prognosis.
